Eiken Chemical Co., Ltd. (TYO:4549)

Market Cap	66.80B
Revenue (ttm)	40.54B
Net Income (ttm)	2.23B
Shares Out	33.07M
EPS (ttm)	64.27
PE Ratio	31.43
Forward PE	19.33
Dividend	58.00 (2.87%)
Ex-Dividend Date	Mar 28, 2025

Volume	70,200
Average Volume	115,450
Open	2,019.00
Previous Close	2,012.00
Day's Range	2,002.00 - 2,024.00
52-Week Range	1,849.00 - 2,568.00
Beta	0.17
RSI	42.10
Earnings Date	May 13, 2025

About Eiken Chemical

Eiken Chemical Co., Ltd. engages in the manufacturing and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1939
• Employees: 757
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4549

Financial Performance

In 2024, Eiken Chemical's revenue was 40.54 billion, an increase of 1.22% compared to the previous year's 40.05 billion. Earnings were 2.23 billion, a decrease of -15.41%.